Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Galapagos NV ADR

GLPG
Current price
37.81 USD +0.61 USD (+1.64%)
Last closed 37.43 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 448 043 008 USD
Yield for 12 month -6.53 %
Week
Month
Year
GLPG
21.11.2021 - 28.11.2021

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of"various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG3667 that has completed Phase 1b trial; and GLPG5101 and GLPG5201, CD19 CAR-T product candidate manufactures at point-of-care, that is in Phase I/II in relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium. Address: Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800

Analytics

WallStreet Target Price

44.71 USD

P/E ratio

Dividend Yield

Current Year

+552 047 233 USD

Last Year

+529 721 922 USD

Current Quarter

+131 136 347 USD

Last Quarter

+163 832 209 USD

Current Year

+538 850 237 USD

Last Year

+527 942 147 USD

Current Quarter

+124 908 771 USD

Last Quarter

+159 169 176 USD

Key Figures GLPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -139 347 008 USD
Operating Margin TTM -25.19 %
PE Ratio
Return On Assets TTM -2.01 %
PEG Ratio
Return On Equity TTM -5.76 %
Wall Street Target Price 44.71 USD
Revenue TTM 543 968 000 USD
Book Value 39.56 USD
Revenue Per Share TTM 0.42 USD
Dividend Share
Quarterly Revenue Growth YOY -11.9 %
Dividend Yield
Gross Profit TTM 4 818 000 USD
Earnings Share -2.56 USD
Diluted Eps TTM -2.56 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY 19 %
Profit Margin -28.14 %

Dividend Analytics GLPG

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GLPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GLPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 81.3008
Enterprise Value Revenue 1.1836
Price Sales TTM 4.5003
Enterprise Value EBITDA 12.148
Price Book MRQ 0.8533

Financials GLPG

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators GLPG

For 52 weeks

31.86 USD 48.07 USD
50 Day MA 35.34 USD
Shares Short Prior Month 2 206 754
200 Day MA 38.67 USD
Short Ratio 10.62
Shares Short 2 244 623
Short Percent 1 %